CLSD - Clearside Biomedical, Inc.
IEX Last Trade
0.93
0.010 1.075%
Share volume: 2,201
Last Updated: Thu 26 Dec 2024 08:24:57 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$0.92
0.01
1.09%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-12 | 2022-11-09 | 2023-03-14 | 2023-05-12 | 2023-08-14 | 2023-11-13 | 2024-03-12 | |
| Total revenue | 347.000 K | 384.000 K | 266.000 K | 330.000 K | 4.000 K | 1.018 M | 859.000 K | 6.345 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 204.000 K | 0.000 | 213.000 K | 142.000 K | 0.000 | |
| Gross profit | 347.000 K | 384.000 K | 266.000 K | 126.000 K | 4.000 K | 805.000 K | 717.000 K | 6.345 M | |
| 10.66% | -30.73% | -52.63% | -96.83% | 20,025.00% | -10.93% | 784.94% | |||
| Operating expenses | 7.993 M | 8.221 M | 6.990 M | 8.196 M | 7.609 M | 8.075 M | 7.771 M | 9.260 M | |
| Selling general and admin | 3.457 M | 2.791 M | 2.353 M | 3.169 M | 3.158 M | 3.127 M | 2.637 M | 2.947 M | |
| Research and development | 4.536 M | 5.430 M | 4.637 M | 5.027 M | 4.451 M | 4.948 M | 5.134 M | 6.313 M | |
| Total expenses | 7.993 M | 8.221 M | 6.990 M | 8.400 M | 7.609 M | 8.288 M | 7.913 M | 9.260 M | |
| 2.85% | -14.97% | 20.17% | -9.42% | 8.92% | -4.52% | 17.02% | |||
| Operating income | -7.646 M | -7.837 M | -6.724 M | -8.070 M | -7.605 M | -7.270 M | -7.054 M | -2.915 M | |
| Ebit | -7.646 M | -7.837 M | -6.724 M | -8.070 M | -7.605 M | -7.270 M | -7.054 M | -2.915 M | |
| Pretax income | -7.644 M | -7.813 M | -7.827 M | -9.663 M | -9.280 M | -9.106 M | -9.267 M | -4.832 M | |
| 2.21% | 0.18% | 23.46% | -3.96% | -1.88% | 1.77% | -47.86% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -7.644 M | -7.813 M | -7.827 M | -9.663 M | -9.280 M | -9.106 M | -9.267 M | -4.832 M | |
| -2.21% | -0.18% | -23.46% | 3.96% | 1.88% | -1.77% | 47.86% | |||
| Net income | -7.644 M | -7.813 M | -7.827 M | -9.663 M | -9.280 M | -9.106 M | -9.267 M | -4.832 M | |
| -2.21% | -0.18% | -23.46% | 3.96% | 1.88% | -1.77% | 47.86% |